|
|
Neuropsychological Profiles and Risk for Dementia-Related Disease in Mothers of Children with Autism Spectrum Disorder |
| 1F32AG079615-01 |
|
NIA |
2022 |
|
|
Assessment of Language and Cognition in Older Deaf Signers |
| 1R01AG074928-01 |
|
NIA |
2022 |
|
|
Targeting language-specific and executive-control networks with transcranial direct current stimulation in aphasic AD |
| 1R01AG075404-01A1 |
|
NIA |
2022 |
|
|
Language Switching with Alzheimers Disease |
| 1R01AG076415-01 |
|
NIA |
2022 |
|
|
Iron Metabolism in Ts65Dn mice, a Model of Down syndrome |
| 1R15AG077421-01 |
|
NIA |
2022 |
|
|
Restoration of proteostasis to address co-occurring conditions in Down Syndrome |
| 1RF1AG078969-01 |
|
NIA |
2022 |
|
|
The role of APP in neurogenesis and AD in Down syndrome |
| 1RF1AG079002-01 |
|
NIA |
2022 |
|
|
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome |
| 3R01AG064579-03S1 |
|
NIA |
2022 |
|
|
Down Syndrome: Toward Optimal Trajectories and Health Equity using Medicaid Analytic eXtract (DS -TO-THE-MAX) |
| 3R01AG073179-01S1 |
|
NIA |
2022 |
|
|
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS) |
| 3U19AG068054-02S2 |
|
NIA |
2022 |